Autotelic Bio is a clinical-stage bioscience company pioneering next-generation nucleic acid therapies to address critical unmet medical needs.
Our proprietary Anti-Sense Oligonucleotide (ASO) discovery platform technologies, ASODE and atDOA (Advanced Targeting Delivery of ASO), enable selective targeting and precise optimization of ASOs. This cutting-edge technology aims to deliver superior efficacy, safety, and tolerability compared to conventional RNA therapies.
Company Details
- Employees
- 13
- Address
- 37, Poeun-Daero 59beon-Gil, Suji-Gu, Yongin-Si,gyeonggi-Do 16864,korea, Republic Of
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.autotelic.co.kr/en/
- Keywords
- Costiera Amalfitana.
- HQ
- yongin-si, Gyeonggi-do
Autotelic Bio Inc. Questions
Autotelic Bio Inc.'s website is http://www.autotelic.co.kr/en/
Autotelic Bio Inc.'s LinkedIn profile is https://kr.linkedin.com/company/autotelic-bio
Autotelic Bio Inc. has
13 employees.
View email and phone details for 13
employees at Autotelic Bio Inc..
Autotelic Bio Inc.'s industry is
Biotechnology Research
Autotelic Bio Inc.'s top competitors are
Hlb Pharma Group,
Qubest Bio,
Dt&cro,
Lotte Biologics,
Ilyang,
Medica Korea Co., Ltd.,
Grapee,
Ctcbio Inc.,
Kcrn Research,
Hanall Biopharma.
Autotelic Bio Inc.'s categories are Biotechnology Research
